BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18193393)

  • 21. Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.
    Sie M; den Dunnen WF; Lourens HJ; Meeuwsen-de Boer TG; Scherpen FJ; Zomerman WW; Kampen KR; Hoving EW; de Bont ES
    PLoS One; 2015; 10(3):e0122555. PubMed ID: 25799134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in Dural Penetration of Clival Chordomas Are Associated with Different Prognosis and Expression of Platelet-Derived Growth Factor Receptor-β.
    Zhai Y; Bai J; Wang S; Du J; Wang J; Li C; Gui S; Zhang Y
    World Neurosurg; 2017 Feb; 98():288-295. PubMed ID: 27506406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
    Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome analysis of childhood low-grade astrocytomas.
    Fisher PG; Tihan T; Goldthwaite PT; Wharam MD; Carson BS; Weingart JD; Repka MX; Cohen KJ; Burger PC
    Pediatr Blood Cancer; 2008 Aug; 51(2):245-50. PubMed ID: 18386785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
    Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.
    Takei H; Yogeswaren ST; Wong KK; Mehta V; Chintagumpala M; Dauser RC; Lau CC; Adesina AM
    J Neurooncol; 2008 Jan; 86(2):183-90. PubMed ID: 17690840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
    Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M
    J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of PDGFR-α, EGFR and c-MET in spinal chordoma: a series of 52 patients.
    Akhavan-Sigari R; Gaab MR; Rohde V; Abili M; Ostertag H
    Anticancer Res; 2014 Feb; 34(2):623-30. PubMed ID: 24510991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.
    Haapasalo JA; Nordfors KM; Hilvo M; Rantala IJ; Soini Y; Parkkila AK; Pastoreková S; Pastorek J; Parkkila SM; Haapasalo HK
    Clin Cancer Res; 2006 Jan; 12(2):473-7. PubMed ID: 16428489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression microarray analysis reveals prognostic markers of survival in high grade astrocytomas.
    Yang J; Hou Z; Wang C; Wang H; Zhang H
    Neurol Res; 2018 Sep; 40(9):744-751. PubMed ID: 29781781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance.
    Antonelli M; Massimino M; Morra I; Garrè ML; Gardiman MP; Buttarelli FR; Arcella A; Giangaspero F
    Neuropathology; 2012 Apr; 32(2):133-8. PubMed ID: 21978279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.
    Fjällskog ML; Lejonklou MH; Oberg KE; Eriksson BK; Janson ET
    Clin Cancer Res; 2003 Apr; 9(4):1469-73. PubMed ID: 12684421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis.
    Hales RK; Shokek O; Burger PC; Paynter NP; Chaichana KL; Quiñones-Hinojosa A; Jallo GI; Cohen KJ; Song DY; Carson BS; Wharam MD
    J Neurooncol; 2010 Aug; 99(1):65-71. PubMed ID: 20043190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of vessels with smooth muscle layer in astrocytic tumors: correlation with histological grade and prognostic significance.
    Sato S; Sato Y; Hatakeyama K; Marutsuka K; Yamashita A; Takeshima H; Asada Y
    Histol Histopathol; 2011 Apr; 26(4):497-504. PubMed ID: 21360443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.
    Turkoglu E; Gurer B; Sanli AM; Dolgun H; Gurses L; Oral NA; Donmez T; Sekerci Z
    Clin Neurol Neurosurg; 2013 Dec; 115(12):2508-13. PubMed ID: 24225484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
    Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis.
    Cossu-Rocca P; Contini M; Uras MG; Muroni MR; Pili F; Carru C; Bosincu L; Massarelli G; Nogales FF; De Miglio MR
    Int J Gynecol Pathol; 2012 Nov; 31(6):570-9. PubMed ID: 23018215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
    Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
    Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining.
    Hwang SL; Hong YR; Chai CY; Lin HJ; Howng SL
    Kaohsiung J Med Sci; 1998 Oct; 14(10):607-15. PubMed ID: 9819502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
    Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
    Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.